Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database
Ioanna Tzoulaki(Academy of Athens), Paul Elliott(Ipsen (France)), Vasa Ćurčin(King's College London), Christopher Millett(Imperial College London), Kamlesh Khunti(University of Leicester), Mark P. Little(National Institutes of Health), Martin R. Wilkins(Hammersmith Hospital), Robert I. Hughes(Imperial College London), Mariam Molokhia(Auckland University of Technology), A. Ng(Imperial College London), Azeem Majeed(Imperial College London)
Cited by 442
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.2k
2. Classification and Diagnosis of Diabetes:<i>Standards of Care in Diabetes—2023</i>
|Diabetes Care|2022|2.4k
Definitions and Diagnosis of Pulmonary Hypertension
|Journal of the American College of Cardiology|2013|1.8k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k